Neptune Petrochemicals Limited
Bookbuilding IPO · NSE
- Price band
- ₹115 - ₹122
- Lot size
- 1,000 shares
- Issue amount
- ₹73.2 cr
- Total subscription
- 4.11×
- Opens
- 28 May 2025
- Closes
- 30 May 2025
- Allotment
- 2 Jun 2025
- Listing
- 4 Jun 2025
Offer at a glance
Issue overview
- Issue size
- 60,00,000 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,15,000
- Fresh issue
- ₹73.2 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,22,000
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,66,53,500
- Shares after issue
- 2,26,53,500
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| INDIVIDUAL | 2 | 2,000 | ₹2,44,000 |
| sHNI | 3 | 3,000 | ₹3,66,000 |
| bHNI | 9 | 9,000 | ₹10,98,000 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | — | 11 |
| NIB | — | 2,553 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 13.91 | 99.02 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-24 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 12.26 | 13.87 | 6.92 |
| ROE | 41.81 | 96.85 | 176.47 |
| ROCE | 55.97 | 117.86 | 170.4 |
| RONW | 31.79 | 65.25 | 93.75 |
| PRE IPO(PE) | 0 | 0 | 0 |
| POST IPO(PE) | 0 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Neptune Petrochemicals Limited, established in October 2021, is involved in the manufacturing and trading of a variety of bitumen products and emulsions. Its product range includes different grades of bitumen such as polymer-modified and crumb-rubber-modified bitumen, which are mainly used in construction and industrial sectors. The company operates three manufacturing units located in Ahmedabad (Gujarat), Panipat (Haryana), and Kamrup (Assam). Along with manufacturing, Neptune also trades bitumen and fuel oils by sourcing them from trusted suppliers to ensure quality and meet customer demands. The company holds certifications in Quality Management (ISO 2015), Environmental Management (ISO 2015), and Occupational Health & Safety (OHSAS 2018), highlighting its commitment to international standards and efficient operations. Neptune sells its products in India and also exports to Nepal and Bhutan. As of December 31, 2024, the company employed 59 people.
Strengths
- Customized Products: Offers special bitumen products for construction, roads, and industrial needs.
- Industry Knowledge: Has a deep understanding of market trends, customer demands, and government rules.
- Focused Approach: Serves different customer groups with tailored solutions for better results.
Risk factors
- Supply Chain Risk: Relying on foreign suppliers can lead to delays or issues due to global tensions or shipping problems.
- Revenue Risk: Depending mostly on bitumen trading makes the company vulnerable to price changes and market ups and downs.
- Customer Growth Challenge: Struggling to gain new customers affordably could slow down growth and reduce profits.
Promoters
Mr. Pareshkumar Subodhchandra Shah
Mrs. Riddhi Pareshkumar Shah
Mr. Sanjaykumar Subodhchandra Shah
Registrar & documents
Lead manager
Beeline Capital Advisors Private Limited
Registrar & contacts
Link Intime India Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Block-B, Office No. 606 Mondeal Heights Nr. Panchratna Party Plot, S. G. Highway,
+91-79 49000599
[email protected]Company website ↗Understanding NEPTUNE IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.